Sunbit UV Measuring Device to Track Sun Behavior

Immunosuppression Clinical Trial

Official title:

An Observational Single Center Pilot Study Using a Wearable UV Sensor (Sunbit) Measuring UV Exposure of Patients at High Risk for Skin Cancer - SUNBIT Study

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02221843
• Other study ID #: KEK2013-0283_Sunbit
• Status: Terminated
• Phase: N/A
• First received: August 19, 2014
• Last updated: July 11, 2016
• Start date: August 2014
• Est. completion date: March 2016

Study information

• Verified date: July 2016
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Observational

Clinical Trial Summary

Sunbit is a new wearable UV dosimeter to measure solar radiation in real time. The purpose of this study is to track sun behavior of patients at high risk for skin cancer, to investigate the feasibility of this prototype in daily life and to investigate the technical accuracy of the Sunbit.

Description:

A total of 20 patients will be included to wear the Sunbit system during the time of 4 weeks. After this 4 weeks Sunbit will be recollected and data in the form of UV Indices will be extracted and analyzed.

Patients will be recruited in the Department of Dermatology of the University Hospital Zürich. The target population comprises patients with a high risk of melanoma and non-melanoma skin cancer, thus especially patients with an immunosuppressive therapy due to organ transplantation.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 10
• Est. completion date: March 2016
• Est. primary completion date: March 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• Age = 18 years

• History of skin cancer (melanoma or NMSC) or patients with high risk of skin cancer (e.g. immunosuppressive therapy)

• Oral and written informed consent

Exclusion Criteria:

• Any medical condition that renders the patient bedridden for the duration of 2 weeks

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Immunosuppression
• Skin Neoplasms

Locations

Country	Name	City	State
Switzerland	Department of Dermatology of the University Hospital Zurich	Zurich

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	difference between the individual UV Indices	sun behavior	after 4 weeks wearing the device	No
Primary	number of days wearing the device	patient compliance	after 4 weeks wearing the device	No
Secondary	difference between measured UV Indices and reference values	technical accuracy of the device	after 4 weeks wearing the device	No

External Links

•   Fahrni, T. Sundroid (renamed Sunbit): Solar Radiation Awareness with Smartphones. 2011